Pre-operative optimisation is a heterogenous group of interventions aimed at improving peri-operative outcomes. To understand the evidence for pre-operative optimisation in the developing world, we systematically reviewed Cochrane reviews on the topic according to the Human Developmental Index (HDI) of the country where patient recruitment occurred. We used summary statistics and cartograms to describe the HDI, year of publication, timing of pre-operative intervention and risk of bias associated with each included trial. We assessed the impact of multinational trials on the risk of bias introduced by countries of differing HDI. Fourhundred and nine trials representing 51 countries and 89,389 randomly allocated participants were summarised in this review. Four-hundred and nineteen out of 451 (93%) trial populations (i.e. a group of study participants from one country) were from high and very high HDI countries. The median (IQR [range]) HDI of countries were 0.862 (0.806-0.892 [0.445-0.949]). Three of the 409 included trials were multinational, representing 32 countries and 37,736 out of 89,389 (42.2%) included participants. Africa was the least represented continent, with only 4 included trials and 566 participants, of which 62.3% were from one multinational trial. The overall risk of bias was high or unclear in 381 out of 409 (93%) trials. Inclusion of multinational trials decreased the proportion of trial populations introducing high or unclear risk of bias by 9.4% (95%CI 5.1-13.7; p < 0.0001). Half of the world's population live in low-and middle-HDI countries. This population is poorly represented in systematically reviewed evidence on pre-operative optimisation. Multinational trials increase the knowledge contribution from low-and middle-HDI countries and decrease risk of bias in systematic reviews.
Introduction
Fitness for surgery has developed from a simple question of survival probability, to the concept of multifactorial optimisation for best possible outcome [1, 2] . In this review, we define pre-operative optimisation as a planned intervention before surgery and anaesthesia that aims to reduce postoperative mortality, morbidity, cost of care, improve the technical success and longevity of the procedure, or accelerate rehabilitation. Pre-operative optimisation holds promise for less developed socioeconomic settings, where the baseline risk of poor surgical outcomes is greater and the cost of complications is arguably more crippling to the system. To facilitate the goal of universal access to safe, affordable surgery and anaesthesia, knowledge of pre-operative optimisation should include knowledge on the translation of preoperative optimisation to a range of socioeconomic settings [3] .
The United Nations Human Developmental Index (HDI) is a measure of a country's socioeconomic development. It is a composite index of gross national income, life expectancy and years of schooling. The index is associated with variations in health status outcomes. For example, low-HDI countries have 10 times the mortality rate of very high-HDI countries for infants and children >5 years, and 40 times the maternal mortality rate (14 vs. 553 death per 100,000 live births) [4] . In the peri-operative setting, the GlobalSurg collaborative has shown HDI to be an independent predictor of both surgical site infection and postoperative mortality [5, 6] .
The HDI, as a measure of socioeconomic status, may predict changes in the baseline risk and the populationattributable fraction for morbidity and mortality. Moreover, the HDI may predict changes in the efficacy of interventions that require complex implementation. If this is the case, the HDI would be useful for the study and implementation of pre-operative optimisation in differing socioeconomic environments [7, 8] .
In order to understand the distribution of published pre-operative optimisation literature across the HDI range, we conducted a systematic review of Cochrane reviews. This review describes pre-operative optimisation according to:
(1) the contribution, (2) the differences in timing of preoperative optimisation and (3) the differences in risk of bias, between HDI categories.
Methods
A systematic review of randomised control trials (referred to hereafter as 'trials') that included a pre-operative intervention was conducted. Trials for inclusion were identified through a two-stage process. In the first stage, we searched for Cochrane reviews that reported on any preoperative care or any postoperative complication. In the second stage, we screened these systematic reviews for trials that included a pre-operative intervention and contained information that allowed us to identify the country of origin. We considered any year and language of publication.
Data were extracted from the Cochrane reviews; where the information was not available in the review, we evaluated the individual trial abstracts or full papers. We contacted the authors of multinational trials for information on the breakdown by country of their study participants.
The unit of measure in our study is a trial population, which we define as the participants of a trial from one country; multinational trials therefore contain > 1 trial population. The online resource Countryeconomy.com was used to match each trial population with the reported HDI for the country of origin and the year of publication [9] .
In the first stage, LDT searched PubMed (search last updated 10 March 2018) using the following search terms: Cohen's Kappa statistic was used to quantify interrater reliability for the classification of individual trials. All analyses were performed with RStudio (Kite-eating tree) [10] .
Results
This analysis includes data from 409 trials, extracted from 37 Cochrane reviews with only 8 studies and 607 participants from low-and middle-HDI countries (Middle East, Asia and Brazil).
Comparison of the risk of bias between HDI groupings
with and without the inclusion of the multinational trail populations are reported in Table 2 . The inclusion of multinational trials significantly reduced the proportion of trial populations at high or unclear risk of bias, by 9.4%.
Discussion
Pre-operative optimisation is a heterogenous group of interventions, supported by a large body of systematically reviewed evidence. However, very little evidence was generated in low-and middle-HDI countries. Extended preoperative optimisation (beginning before admission for surgery) is almost exclusively studied in high-and very high- There is a dearth of pre-operative optimisation information from low-and middle-HDI countries with a stark absence of data from Africa, Central America and parts of Asia. Extended pre-operative optimisation is almost Understanding the relationship between pre-operative optimisation and socioeconomic status is essential for research strategy and for translation of knowledge from a clinical trial to a healthcare system, policy and the bed-side.
We propose three mechanisms that may act to change the impact of pre-operative optimisation in countries with different HDIs.
1 Differences in baseline risk may increase the absolute effect of interventions. A higher baseline risk for morbidity and mortality in lower HDI countries [5, 6] suggests that pre-operative optimisation interventions may cause a greater absolute risk reduction in these countries compared with higher HDI countries. Apart from the cost-benefit for clinical practice, this may also translate to smaller sample size requirements for multinational trials that include lower HDI countries.
2 Differences in the population attributable fraction may alter the impact of interventions on morbidity and mortality; for example, infectious complications are thought to be responsible for a greater proportion of peri-operative deaths in Africa than in high-HDI countries [6] , so that infection prevention strategies will have greater impact on peri-operative mortality in Africa than in higher HDI countries.
3 Differences in implementation or provider proficiency may alter the efficacy of a complex intervention [57] .
Universal access to safe surgical care is a recognised objective of the World Health Organization.
Achieving this goal will require strategic allocation of resources to minimise waste and maximise benefit [3] .
The care pathway for a surgical disease extends all the way from diagnosis through pre-operative care, the surgical procedure, to recovery, rehabilitation and long- There is a scarcity of high-quality evidence for preoperative optimisation from low-and middle-HDI countries.
This knowledge gap confounds value-based decision making in countries where the impact of pre-operative optimisation is likely to be the greatest. Increased participation by low-and middle-HDI countries in multinational trials can improve representation and reduce the risk of bias in systematically reviewed literature on this topic. 
